Exhibiting a y-o-y growth of 3.8%, the United States phlebotomy equipment industry revenue is estimated to total US$ 4.2 billion in 2024. Demand for phlebotomy equipment in the United States will likely rise at a CAGR of 3.3% throughout the forecast period. By 2034, the United States industry size is set to reach US$ 5.8 billion.
Sales of phlebotomy supplies are predicted to outpace other product sales during the next ten years. This can be attributed to increasing usage of syringes and other phlebotomy devices across different healthcare settings. The target segment will likely grow at 3.9% CAGR through 2034.
United States Phlebotomy Equipment Industry Insights
| Attributes | Key Insights |
|---|---|
| Base Value (2023) | US$ 4.0 billion |
| Estimated United States Phlebotomy Equipment Industry Value (2024) | US$ 4.2 billion |
| Projected United States Phlebotomy Equipment Industry Size (2034) | US$ 5.8 billion |
| Value CAGR (2024 to 2034) | 3.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Phlebotomy equipment demand in the United States is increasing steadily, and the trend will likely persist during the forecast period. This can be attributed to expanding healthcare infrastructure and increasing number of phlebotomy procedures performed in the nation.
Phlebotomy equipment are becoming essential equipment in healthcare settings. They are used for the safe and efficient collection of blood samples from patients.
Increasing prevalence of chronic diseases like cancer and diabetes across the United States is expected to drive demand for phlebotomy products. This is because these diseases need regular testing for detection and monitoring.
Another key factor positively impacting phlebotomy equipment sales is the growing emphasis on early disease diagnosis, coupled with rising demand for blood tests. Subsequently, rising popularity of point-of-care (POC) testing will likely create growth opportunities for phlebotomy equipment in the United States.
Rise in blood donation drives and campaigns across the United States are anticipated to uplift phlebotomy equipment demand. New initiatives and projects are being launched to promote the importance of Voluntary non-remunerated blood donations. This will benefit the target industry.
The phlebotomy industry is witnessing a shift toward automated and robotic solutions to enhance accuracy and efficiency. The emphasis on personalized medicine and biomarker identification is necessitating the development of phlebotomy equipment. These are capable of accurately collecting small-volume samples for specialized diagnostic tests.
Investing in robotic-assisted phlebotomy tools with autonomous vein detection, blood extraction, and proper sample handling has transformative potential for the field.
Public health campaigns and educational initiatives can empower patients to recognize symptoms and seek timely treatment. This, in turn, is expected to create growth opportunities for phlebotomy equipment manufacturers in the United States.
There is, however, a lack of awareness among patients regarding phlebotomy equipment and their applications, potentially hindering timely disease diagnosis and treatment. This may limit growth of the phlebotomy equipment industry in the United States over the next ten years.
Sales of phlebotomy equipment in the United States grew at a CAGR of 2.8% from 2019 to 2023. Accordingly, the United States accounted for 35.7% of the global phlebotomy equipment industry, valued at US$ 11.2 billion.
The historical evolution of phlebotomy reveals a gradual transition towards automated and robotic solutions driven by the increasing demand for precision and efficiency. Looking ahead, the industry's future lies in innovations. Top players will look to develop portable, user-friendly, and remotely controlled phlebotomy equipment to overcome challenges in accessing healthcare services.
Creating machinery tailored to the demands of personalized medicine, enabling effective and minimally invasive collection of specific biomarkers, will open new avenues for business. The industry's trajectory indicates transformative potential through investments in robotic-assisted phlebotomy tools capable of autonomous vein detection and sample handling.
Principal Consultant
The need for diagnostic testing in the United States is increasing as patient numbers rise and healthcare services remain at capacity. This will likely create a plethora of growth opportunities for phlebotomy equipment manufacturers in the nation.
Demand for diagnostic testing continues to rise in the United States due to converging factors such as rising prevalence of communicable and non-communicable diseases. This suggests that there will be an increasing need for phlebotomy equipment in the nation through 2034.
There is also a sharp increase in geriatric population across the United States. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), total number of older adults in the United States is estimated to reach 80.8 million in 2040.
As people age, they are more likely to develop chronic diseases that require blood testing. Thus, growing geriatric population is anticipated to play a key role in driving demand for phlebotomy services and equipment.
Outbreaks of infectious diseases such as COVID-19 highlight the importance of diagnostic testing in disease surveillance, containment, and management. The need for rapid and accurate diagnostic tests during such outbreaks acts as a catalyst triggering phlebotomy equipment sales.
With growing concerns about healthcare-associated infections, bloodborne pathogens, and needlestick injuries, there is a growing emphasis on ensuring the safety of blood collection procedures for both patients and healthcare professionals. Phlebotomy equipment plays an important role in promoting blood safety by incorporating features such as safety-engineered needles and needleless blood collection systems.
The growing emphasis on enhancing blood safety during blood donation is positively impacting phlebotomy equipment sales. These products help maintain safe and effective procedures for collecting, storing, and using donated blood.
Phlebotomy equipment, including devices for blood collection and sample handling, requires trained and skilled medical professionals to operate effectively. Thus, shortage of skilled phlebotomists can limit growth of the target industry.
The lack of skilled professionals in phlebotomy poses a significant restraint by impacting training costs and time, raising concerns about quality and accuracy, and increasing the risk of adverse events. Addressing the skills gap through targeted training and education initiatives is essential for unlocking the full potential of phlebotomy equipment in the healthcare sector.
Medical errors, majorly caused due to unskilled workers, are the third-leading cause of death after heart disease and cancer. The US Food and Drug Administration receives over 100,000 reports of medication errors each year.
Around 41% of the United States citizens have claimed to be the sufferer of a medical error. This, in turn, is negatively impacting the phlebotomy equipment industry, and the trend may continue during the forecast period.
Related Industry Growth Outlook Scenario
| Particulars | Value CAGR |
|---|---|
| United States Phlebotomy Equipment Industry | 3.3% |
| Vacuum Blood Collection Device Industry | 6.3% |
| Blood Collection Device Industry | 6.5% |
In the section below, the United States phlebotomy equipment industry is compared to the blood collection device industry and the vacuum blood collection device industry based on growth factors and key trends. This will help players to get a better understanding of the target industry.
Analysis of Phlebotomy Equipment Industry in the United States:
| Attributes | Sales Outlook for Phlebotomy Tool Industry in the United States |
|---|---|
| CAGR (2024 to 2034) | 3.3% |
| Growth Factor | Rising cases of chronic and infectious diseases, growing demand for blood tests, and increasing number of accidents & trauma cases are expected to boost growth of the phlebotomy equipment industry in the United States. |
| Trends in the United States Phlebotomy Equipment Industry | Growing focus on preventive care and advancement in phlebotomy devices are key trends shaping the United States blood drawing equipment industry. |
Blood Collection Device Industry Outlook:
| Attributes | Blood Collection Device Sales Forecast |
|---|---|
| CAGR (2024 to 2034) | 6.5% |
| Growth Factor | Increasing prevalence of infectious diseases globally is expected to drive growth of the blood collection device industry. |
| Key Trends in Blood Collection Device Industry | A key growth-shaping trend is the development and usage of automated blood collection devices. |
Vacuum Blood Collection Device Industry Analysis:
| Attributes | Vacuum Blood Collection Device Demand Outlook |
|---|---|
| CAGR (2024 to 2034) | 6.3% |
| Growth Factor | Rising need for blood tests for disease detection and monitoring is expected to drive demand for vacuum blood collection devices. |
| Key Trends in Vacuum Blood Collection Industry | Innovation in vacuum blood collection devices will likely support industry expansion through 2034. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the estimated growth rates of the top regions across the United States for the forecast period. The Northeast United States and the Midwest United States are set to record high CAGRs of 4.8% and 4.2%, respectively, through 2034.
Growth Outlook by Key Regions
| Region | Value CAGR |
|---|---|
| Northeast United States | 4.8% |
| Midwest United States | 4.2% |
| Southeast United States | 2.7% |
| Southwest United States | 2.0% |
| West United States | 2.3% |
The Northeast United States phlebotomy equipment industry is poised to grow at 4.8% CAGR during the assessment period. It will likely total US$ 1.2 billion in 2024, representing 30.5% of the United States industry.
The presence of renowned medical research institutions and academic medical centers in states like New York fuels the demand for phlebotomy equipment. These institutions often drive innovation and set standards for medical practices, influencing the widespread adoption of advanced phlebotomy technologies.
The region is densely populated, with a concentration of healthcare facilities, hospitals, clinics, and diagnostic laboratories. The high population density results in an increased need for regular blood tests, diagnostic procedures, and medical treatments, thereby driving the demand for phlebotomy equipment.
The Southwest region takes center stage in the United States phlebotomy equipment industry, claiming a noteworthy share of 21.8% in 2024. Over the forecast period, sales of phlebotomy equipment in the Southwest United States are projected to soar at 2.0% CAGR.
Southwest states like North Carolina and Florida are often at the forefront of adopting advanced healthcare technologies and practices. The emphasis on cutting-edge medical solutions and the incorporation of automated and robotic systems for phlebotomy procedures are boosting sales growth in the region.
The awareness and emphasis on preventive healthcare in this region also contribute to the demand for phlebotomy equipment. Regular blood screenings and diagnostic tests are crucial to preventive healthcare practices, leading to a sustained need for reliable and efficient phlebotomy tools.
The table below offers compelling insights into top segments in the United States phlebotomy equipment industry. This information will likely help players maximize profits and stay ahead of the curve by investing in popular and demanding products.
Growth Outlook by Key Products
| Products | Value CAGR |
|---|---|
| Phlebotomy Supplies | 3.9% |
| Phlebotomy Carts | 2.0% |
| Phlebotomy Cabinets | 1.8% |
| Phlebotomy Chairs | 2.6% |
| Phlebotomy Tables | 1.4% |
As per the latest analysis, sales of phlebotomy supplies in the United States are expected to grow at a higher CAGR of 3.9% during the forecast period. The target segment will likely generate revenue worth US$ 2.9 billion in 2024.
Rising usage of syringes, blood collection needles, and other phlebotomy products for blood collection across different settings is driving the target segment. Similarly, innovation in phlebotomy devices like syringes will likely boost the segment.
Phlebotomy supplies play an integral role in ensuring the integrity and precision of blood collection procedures across diverse healthcare settings. Their critical nature lies in their ability to guarantee safe, efficient, and standardized processes essential for diagnostic evaluations and therapeutic interventions.
As technology advances, phlebotomy supplies continue to evolve, incorporating innovative features that enhance user experience, accuracy, and patient comfort. This will foster segment growth during the assessment period.
Growth Outlook by Key Usage
| Usage | Value CAGR |
|---|---|
| Disposable Devices | 4.1% |
| Reusable Devices | 2.0% |
In the United States, demand is expected to remain high for disposable phlebotomy devices throughout the forecast period. The target segment will likely account for a value share of 66.1% in 2024 and further grow at 4.1% CAGR during the next ten years.
The phlebotomy equipment industry is witnessing a significant paradigm shift, with disposable devices taking center stage. This surge in prominence is propelled by their unparalleled convenience, cost-effectiveness, and heightened infection control measures.
Disposable devices emerge as a strategic and sustainable solution in response to the increasing demand for single-use, hygienic medical equipment. They eliminate the risk of cross-contamination between patients.
Leading end users like hospitals and diagnostic centers are inclined towards using disposable needles and other single-use phlebotomy devices to curb the risk of cross-contamination. This will continue to foster segment growth over the next ten years.
The industry is experiencing a notable surge in innovation within this segment. Top manufacturers are focusing on designing products that not only meet clinical requirements but also align with the broader healthcare trend toward sustainability and reduced environmental impact.
Growth Outlook by Key End User
| End-user | Value CAGR |
|---|---|
| Hospitals | 3.2% |
| Ambulatory Surgical Centers | 2.1% |
| Diagnostic Laboratories | 5.0% |
| Skilled Nursing Facilities | 2.5% |
| Long Term Care Centers | 0.7% |
| Specialty Clinics | 4.4% |
| Blood Banks | 3.8% |
| Home Healthcare Providers | 1.6% |
| Others | 1.1% |
As per the latest report, hospitals remain prominent end users of phlebotomy equipment across the United States. This is attributed to rising volume of diagnostic tests, blood transfusions, and surgical procedures in hospitals.
Phlebotomy equipment usage in hospitals is expected to increase with a CAGR of 3.2% during the assessment period. The target segment will likely hold 25.0% of the United States phlebotomy equipment industry share in 2024.
Hospitals, with their diverse and comprehensive healthcare services, showcase the broad spectrum of applications for phlebotomy tools. The demand within these institutions underscores the industry's responsiveness to the evolving needs of healthcare professionals, patients, and the broader healthcare system.
Leading manufacturers of phlebotomy equipment are focusing on developing innovative products, such as blood collection devices with features like self-healing septas and retractable needles, to enhance safety, efficiency, and patient comfort during blood draws. They also provide specific equipment for hospitals, blood banks, or mobile phlebotomy units.
Phlebotomy equipment companies ensure their products meet all safety and compliance standards in this highly regulated industry. Further, they are employing strategies like partnerships, distribution agreements, and acquisitions to expand their footprint.
Recent Developments in the United States Phlebotomy Equipment Industry
| Attribute | Details |
|---|---|
| Estimated Value (2024) | US$ 4.2 billion |
| Projected Industry Size (2034) | US$ 5.8 billion |
| Expected CAGR (2024 to 2034) | 3.3% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Industry Analysis | US$ billion for Value |
| Key Regions Covered | Northeast United States; Midwest United States; Southeast United States; Southwest United States; and West United States |
| Key States Covered | New York, New Jersey, Massachusetts, Connecticut, Maryland, Rest of North East, Minnesota, Wisconsin, Illinois, Michigan, Ohio, Indiana, Rest of Midwest, North Carolina, South Carolina, Florida, Virginia, Rest of Southeast, Louisiana, Oklahoma, Arizona, Texas, New Mexico, Rest of Southwest, Washington, California, Colorado, Utha, Neveda and Rest of West |
| Key Segments Covered | Product, Usage, End-user, and Region |
| Key Companies Profiled | Cardinal Health; BD; Terumo Corporation; SARSTEDT AG & Co. KG; Medline Industries, LP.; Heathrow Scientific; Marketlab; Kawasumi Laboratories America; United Metal Fabricators, Inc.; Hill Laboratories Company; Clinton Industries, Inc.; Brandt Industries; B. Braun Medical Inc.; O&M Halyard; NIPRO; STRECK; Innovative Med Tech. |
| Report Coverage | Industry Forecast, Competition Intelligence, DROT Analysis, Industry Dynamics and Challenges, Strategic Growth Initiatives |
The United States industry value is set to reach US$ 4.2 billion in 2024.
Sales in the United States are expected to rise at 3.3% CAGR.
The United States phlebotomy equipment industry size is projected to reach US$ 5.8 billion by 2034.
The target industry expanded at a CAGR of 2.8% from 2019 to 2023.
The Northeast United States industry is set to expand at 4.8% CAGR.
Syringes, needles, tourniquets, non-sterile gloves, scrubs, and gauze, among others.
Phlebo refers to a procedure in which a needle is used to take blood from a vein.
Scrubs, needles, non-sterile gloves, alcohol pads, labels, and gauze, among others.
1. Executive Summary
1.1. United States Industry Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Industry Overview
2.1. Industry Coverage / Taxonomy
2.2. Industry Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Industry Trends
3.1. Key Trends Impacting the Industry
3.2. Development/Innovation Trends
4. Value-Added Insights
4.1. Product Adoption/Usage Analysis-By State
4.2. Regulatory Scenario
4.3. Value Chain Analysis
4.4. Key Distributor List
4.5. Import-Export Scenario
4.6. Unmet Needs and Opportunities
4.7. PESTEL Analysis
4.8. Porter’s Analysis
5. Industry Background
5.1. Macro-Economic Factors
5.1.1. United States Per-Capita Healthcare Expenditure
5.1.2. R&D funding by Region
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Rising Healthcare Awareness
5.2.3. Infectious Disease Outbreaks
5.2.4. Cost of Product
5.2.5. Regulatory Dynamics
5.2.6. Growing Awareness and Screening Programs
5.2.7. Increasing Number of Diagnostic Laboratories
5.2.8. Patient-Centric Care and Personalized Medicine
5.3. Industry Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Industry Demand (Volume in Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Industry Volume (Units) Analysis, 2019 to 2023
6.2. Current and Future Industry Volume (Units) Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
7. Industry- Pricing Analysis
7.1. United States Average Pricing Benchmark Analysis
7.2. Regional Average Pricing Benchmark Analysis
7.3. Pricing Assumptions
8. Industry Demand (in Value or Size in US$ billion) Analysis 2019 to 2023 and Forecast, 2024 to 2034
8.1. Historical Industry Value (US$ billion) Analysis, 2019 to 2023
8.2. Current and Future Industry Value (US$ billion) Projections, 2024 to 2034
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
9.1. Introduction / Key Findings
9.2. Historical Industry Size (US$ billion) & Volume (Units) Analysis By Product, 2019 to 2023
9.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034
9.3.1. Phlebotomy Supplies
9.3.1.1. Syringes
9.3.1.2. Blood Collection Needles
9.3.1.3. Blood Draw Trays
9.3.1.4. Evacuated Collection Tubes
9.3.1.5. Tourniquets
9.3.1.6. Non-sterile Gloves
9.3.1.7. Scrubs
9.3.1.8. Gauze or Bandages
9.3.1.9. Blood Safety Lancets
9.3.1.10. Alcohol Pads
9.3.2. Phlebotomy Carts
9.3.3. Phlebotomy Cabinets
9.3.4. Phlebotomy Chairs
9.3.5. Phlebotomy Tables
9.4. Industry Attractiveness Analysis by Product
10. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Usage
10.1. Introduction / Key Findings
10.2. Historical Industry Size (US$ billion) By Usage, 2019 to 2023
10.3. Current and Future Industry Size (US$ billion) Analysis and Forecast By Usage, 2024 to 2034
10.3.1. Disposable Devices
10.3.2. Reusable Devices
10.4. Industry Attractiveness Analysis By Usage
11. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
11.1. Introduction / Key Findings
11.2. Historical Industry Size (US$ billion) By End User, 2019 to 2023
11.3. Current and Future Industry Size (US$ billion) Analysis and Forecast by End User, 2024 to 2034
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Diagnostic Laboratories
11.3.4. Skilled Nursing Facilities
11.3.5. Long Term Care Centers
11.3.6. Specialty Clinics
11.3.7. Blood Banks
11.3.8. Home Health Care Providers
11.3.9. Others
11.4. Industry Attractiveness Analysis by End User
12. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
12.1. Introduction / Key Findings
12.2. Historical Industry Size (US$ billion) & Volume (Units) Trend Analysis by Region, 2019 to 2023
12.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast by Region, 2024 to 2034
12.3.1. Northeast United States
12.3.2. Midwest United States
12.3.3. Southeast United States
12.3.4. Southwest United States
12.3.5. West United States
12.4. Industry Attractiveness Analysis by Region
13. Northeast Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Industry Size (US$ billion) & Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
13.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast by Industry Taxonomy, 2024 to 2034
13.3.1. By States
13.3.1.1. New York
13.3.1.2. New Jersey
13.3.1.3. Massachusetts
13.3.1.4. Connecticut
13.3.1.5. Maryland
13.3.1.6. Rest of North East
13.3.2. By Product
13.3.3. By Usage
13.3.4. By End User
13.4. Industry Attractiveness Analysis
13.4.1. By States
13.4.2. By Product
13.4.3. By Usage
13.4.4. By End User
13.5. State-Wise Analysis
13.5.1. New York Industry Analysis
13.5.1.1. Introduction
13.5.1.2. Industry Analysis and Forecast by Industry Taxonomy
13.5.1.2.1. By Product
13.5.1.2.2. By Usage
13.5.1.2.3. By End User
13.5.2. New Jersey Industry Analysis
13.5.2.1. Introduction
13.5.2.2. Industry Analysis and Forecast by Industry Taxonomy
13.5.2.2.1. By Product
13.5.2.2.2. By Usage
13.5.2.2.3. By End User
13.5.3. Massachusetts Industry Analysis
13.5.3.1. Introduction
13.5.3.2. Industry Analysis and Forecast by Industry Taxonomy
13.5.3.2.1. By Product
13.5.3.2.2. By Usage
13.5.3.2.3. By End User
13.5.4. Connecticut Industry Analysis
13.5.4.1. Introduction
13.5.4.2. Industry Analysis and Forecast by Industry Taxonomy
13.5.4.2.1. By Product
13.5.4.2.2. By Usage
13.5.4.2.3. By End User
13.5.5. Maryland Industry Analysis
13.5.5.1. Introduction
13.5.5.2. Industry Analysis and Forecast by Industry Taxonomy
13.5.5.2.1. By Product
13.5.5.2.2. By Usage
13.5.5.2.3. By End User
13.5.6. Rest of North East Industry Analysis
13.5.6.1. Introduction
13.5.6.2. Industry Analysis and Forecast by Industry Taxonomy
13.5.6.2.1. By Product
13.5.6.2.2. By Usage
13.5.6.2.3. By End User
14. Midwest Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Industry Size (US$ billion) & Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
14.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast by Industry Taxonomy, 2024 to 2034
14.3.1. By State
14.3.1.1. Minnesota
14.3.1.2. Wisconsin
14.3.1.3. Illinois
14.3.1.4. Michigan
14.3.1.5. Ohio
14.3.1.6. Indiana
14.3.1.7. Rest of Midwest
14.3.2. By Product
14.3.3. By Usage
14.3.4. By End User
14.4. Industry Attractiveness Analysis
14.4.1. By State
14.4.2. By Product
14.4.3. By Usage
14.4.4. By End User
14.5. Industry Trends
14.6. Drivers & Restraints Impact Analysis
14.7. Key Industry Players Intensity Mapping
14.8. State-Wise Analysis
14.8.1. Minnesota Industry Analysis
14.8.1.1. Introduction
14.8.1.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Usage
14.8.1.2.3. By End User
14.8.2. Wisconsin Industry Analysis
14.8.2.1. Introduction
14.8.2.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Usage
14.8.2.2.3. By End User
14.8.3. Illinois Industry Analysis
14.8.3.1. Introduction
14.8.3.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Usage
14.8.3.2.3. By End User
14.8.4. Michigan Industry Analysis
14.8.4.1. Introduction
14.8.4.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Usage
14.8.4.2.3. By End User
14.8.5. Ohio Industry Analysis
14.8.5.1. Introduction
14.8.5.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Usage
14.8.5.2.3. By End User
14.8.6. Indiana Industry Analysis
14.8.6.1. Introduction
14.8.6.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Usage
14.8.6.2.3. By End User
14.8.7. Rest of Midwest Industry Analysis
14.8.7.1. Introduction
14.8.7.2. Industry Analysis and Forecast by Industry Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Usage
14.8.7.2.3. By End User
15. Southeast Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Industry Size (US$ billion) & Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
15.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast by Industry Taxonomy, 2024 to 2034
15.3.1. By States
15.3.1.1. North Carolina
15.3.1.2. South Carolina
15.3.1.3. Florida
15.3.1.4. Virginia
15.3.1.5. Rest of Southeast
15.3.2. By Product
15.3.3. By Usage
15.3.4. By End User
15.4. Industry Attractiveness Analysis
15.4.1. By States
15.4.2. By Product
15.4.3. By Usage
15.4.4. By End User
15.5. Industry Trends
15.6. Drivers & Restraints Impact Analysis
15.7. Key Industry Players Intensity Mapping
15.8. State-Wise Analysis
15.8.1. North Carolina Industry Analysis
15.8.1.1. Introduction
15.8.1.2. Industry Analysis and Forecast by Industry Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Usage
15.8.1.2.3. By End User
15.8.2. South Carolina Industry Analysis
15.8.2.1. Introduction
15.8.2.2. Industry Analysis and Forecast by Industry Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Usage
15.8.2.2.3. By End User
15.8.3. Florida Industry Analysis
15.8.3.1. Introduction
15.8.3.2. Industry Analysis and Forecast by Industry Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Usage
15.8.3.2.3. By End User
15.8.4. Virginia Industry Analysis
15.8.4.1. Introduction
15.8.4.2. Industry Analysis and Forecast by Industry Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Usage
15.8.4.2.3. By End User
15.8.5. Rest of Southeast Industry Analysis
15.8.5.1. Introduction
15.8.5.2. Industry Analysis and Forecast by Industry Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Usage
15.8.5.2.3. By End User
16. Southwest Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Industry Size (US$ billion) & Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
16.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast by Industry Taxonomy, 2024 to 2034
16.3.1. By States
16.3.1.1. Louisiana
16.3.1.2. Oklahoma
16.3.1.3. Arizona
16.3.1.4. Texas
16.3.1.5. New Mexico
16.3.1.6. Rest of Southwest
16.3.2. By Product
16.3.3. By Usage
16.3.4. By End User
16.4. Industry Attractiveness Analysis
16.4.1. By State
16.4.2. By Product
16.4.3. By Usage
16.4.4. By End User
16.5. Industry Trends
16.6. Drivers & Restraints Impact Analysis
16.7. Key Industry Players Intensity Mapping
16.8. State-Wise Analysis
16.8.1. Louisiana Industry Analysis
16.8.1.1. Introduction
16.8.1.2. Industry Analysis and Forecast by Industry Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Usage
16.8.1.2.3. By End User
16.8.2. Oklahoma Industry Analysis
16.8.2.1. Introduction
16.8.2.2. Industry Analysis and Forecast by Industry Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Usage
16.8.2.2.3. By End User
16.8.3. Arizona Industry Analysis
16.8.3.1. Introduction
16.8.3.2. Industry Analysis and Forecast by Industry Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Usage
16.8.3.2.3. By End User
16.8.4. Texas Industry Analysis
16.8.4.1. Introduction
16.8.4.2. Industry Analysis and Forecast by Industry Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Usage
16.8.4.2.3. By End User
16.8.5. New Mexico Industry Analysis
16.8.5.1. Introduction
16.8.5.2. Industry Analysis and Forecast by Industry Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Usage
16.8.5.2.3. By End User
16.8.6. Rest of Southwest Industry Analysis
16.8.6.1. Introduction
16.8.6.2. Industry Analysis and Forecast by Industry Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Usage
16.8.6.2.3. By End User
17. West Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Industry Size (US$ billion) & Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
17.3. Current and Future Industry Size (US$ billion) & Volume (Units) Analysis and Forecast by Industry Taxonomy, 2024 to 2034
17.3.1. By States
17.3.1.1. Washington
17.3.1.2. California
17.3.1.3. Usageado
17.3.1.4. Utha
17.3.1.5. Naveda
17.3.1.6. New Mexico
17.3.1.7. Rest of West
17.3.2. By Product
17.3.3. By Usage
17.3.4. By End User
17.4. Industry Attractiveness Analysis
17.4.1. By State
17.4.2. By Product
17.4.3. By Usage
17.4.4. By End User
17.5. Industry Trends
17.6. Drivers & Restraints Impact Analysis
17.7. Key Industry Players Intensity Mapping
17.8. State-Wise Analysis
17.8.1. Washington Industry Analysis
17.8.1.1. Introduction
17.8.1.2. Industry Analysis and Forecast by Industry Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Usage
17.8.1.2.3. By End User
17.8.2. California Industry Analysis
17.8.2.1. Introduction
17.8.2.2. Industry Analysis and Forecast by Industry Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Usage
17.8.2.2.3. By End User
17.8.3. Colorodo Industry Analysis
17.8.3.1. Introduction
17.8.3.2. Industry Analysis and Forecast by Industry Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Usage
17.8.3.2.3. By End User
17.8.4. Utha Industry Analysis
17.8.4.1. Introduction
17.8.4.2. Industry Analysis and Forecast by Industry Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Usage
17.8.4.2.3. By End User
17.8.5. Naveda Industry Analysis
17.8.5.1. Introduction
17.8.5.2. Industry Analysis and Forecast by Industry Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By Usage
17.8.5.2.3. By End User
17.8.6. Rest of West Countries Industry Analysis
17.8.6.1. Introduction
17.8.6.2. Industry Analysis and Forecast by Industry Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By Usage
17.8.6.2.3. By End User
18. Industry Structure Analysis
18.1. Industry Analysis by Tier of Companies
18.2. Industry Share Analysis of Top Players (%)
18.3. Industry Presence Analysis
18.3.1. Regional footprint of Players
18.3.2. Channel Foot Print by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Branding and Promotional Strategies, By Key Players
19.4. Competition Deep Dive
19.4.1. Cardinal Health
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Key Financials
19.4.1.4. SWOT Analysis
19.4.1.5. Key Developments
19.4.1.6. Sales Footprint
19.4.1.7. Strategy Overview
19.4.1.7.1. Industrying Strategy
19.4.1.7.2. Product & Service Strategy
19.4.1.7.3. Channel Strategy
19.4.2. BD
19.4.3. Terumo Corporation
19.4.4. SARSTEDT AG & Co. KG
19.4.5. Medline Industries, LP.
19.4.6. Heathrow Scientific
19.4.7. Industrylab
19.4.8. Kawasumi Laboratories America
19.4.9. United Metal Fabricators, Inc.
19.4.10. Hill Laboratories Company
19.4.11. Clinton Industries, Inc.
19.4.12. Brandt Industries
19.4.13. B. Braun Medical Inc.
19.4.14. O&M Halyard
19.4.15. NIPRO
19.4.16. STRECK
19.4.17. Innovative Med Tech.
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Phlebotomy Equipment Industry Analysis in the United States
